查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1404790

次世代定序服务市场规模、份额和趋势分析报告：按服务类型、工作流程、最终用途、地区和细分市场趋势：2024-2030

Next-generation Sequencing Services Market Size, Share & Trends Analysis Report By Service Type (Human Genome Sequencing, Gene Regulation Services), By Workflow, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

次世代定序服务市场成长与趋势：

Grand View Research, Inc. 的最新报告显示，到 2030 年，全球次世代定序服务市场规模预计将达到 244.8 亿美元。

预计2024年至2030年复合年增长率为22.68%。次世代定序（NGS）技术的发展在重现性和降低成本方面彻底改变了基因定序。因此，NGS 技术的一些进步已被引入，以促进其在临床实验室和医院中的使用。目前该领域的大多数创新都围绕着简化 seq 技术并使其使用更加复杂。这些因素正在推动众多最终用户采用 NGS 服务。

在过去的五年里，次世代定序仪已经从研究进展到临床应用。大约14个国家已经启动了大规模基因定序计划，预计到2025年将有约6,000万人的基因组被分析。由于基于 SEQ 的基因检测的成长趋势，传统疾病检测服务供应商正在扩大其产品组合。例如，ARUP实验室于2022年3月宣布推出新冠状病毒检测，IDbyDNA, Inc.与另一家公司合作推出新冠状病毒检测、针对呼吸道疾病和其他呼吸道疾病的NGS检测。

製药和生物技术行业高通量测序的不断增长趋势要求开发高通量测序平台，以提高速度和便利性并简化工作流程。因此，该公司正在专注于开发简化样品扩增、精製和启动输入的解决方案。 2022 年 3 月，Illumina 宣布发布 TruSigh Oncology (TSO) 综合版（EU）。它是一种综合诊断，可评估多个肿瘤基因和指标，以确定患者的个别癌症分子谱。此体外诊断（IVD）套件将有助于影响整个欧洲癌症患者的基因组测定，并将首先在欧洲进行全球首次亮相。

次世代定序服务市场报告亮点

  • 按服务类型划分，由于全基因组和全EXOME定序的日益普及，人类基因组定序在 2023 年占据了最大的销售份额。
  • 基因调控服务，尤其是小 RNA 定序和 ChIP-seq，预计在预测期内将以良好的速度成长。对 RNA 定序的投资不断增加正在推动基因调控服务的成长。
  • 与其他工作流程步骤相比，定序服务的收益占有率较大可能是由于安装的定序平台数量不断增加。这一步骤的高昂维护和恢復成本也带来了更高的收益。
  • 按最终用途划分，由于NGS技术在癌症预后和诊断中的应用不断扩大，以及学术机构和大学推出重大计划，大学和其他研究机构细分市场将在2023年增长，占收益占有率。
  • 由于该地区技术普及高，并且有足够的资金来采用该技术并获得针对疾病的研究成果，北美在 2023 年占据了市场主导地位。
  • GENEWIZ 和 Novogene 等公司基于主要 NGS 开发商的平台提供 NGS 服务。同时，Illumina、BGI等公司开发定序设备并向研究机构提供服务。
  • 2021年11月，Novogene在日本举行的第44届日本分子生物学会（MSBJ）年会上表示，将专门针对日本客户推出单细胞定序服务。
  • GENEWIZ 科学家正在帮助确定计划的 NGS 解决方案。 NeXT Dx 测试由 Personalis, Inc. 推出，旨在帮助肿瘤学家为癌症患者确定新的治疗方法和临床试验选择。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场趋势及展望
  • 市场动态
    • 价格连续下跌
    • 对妇女和生殖健康的认识不断提高
    • 临床NGS实施所采取的策略
  • 市场抑制因素分析
    • 实施大规模 NGS 分析工作流程的挑战
    • 单细胞定序的分析挑战
  • 营商环境分析
    • PESTEL分析
    • 波特五力分析
    • COVID-19感染疾病的影响分析

第四章 服务类型业务分析

  • 全球次世代定序服务市场：服务类型变化分析
  • 人类基因组解码服务
  • 单细胞定序服务
  • 基于微生物基因组的定序服务
  • 基因控制服务
    • 小RNA测序服务
    • 晶片测序服务
    • 其他基于基因调控的服务
  • 动植物定序服务
  • 其他定序服务

第五章 工作流程业务分析

  • 全球次世代定序服务市场：工作流程变化分析
  • 预测序服务
  • 序列服务
  • 资料分析服务

第六章 最终用途业务分析

  • 全球次世代定序服务市场：最终用途变异分析
  • 大学及其他研究机构
  • 医院和诊所
  • 製药和生物技术公司
  • 其他的

第七章 区域业务分析

  • 2022年及2030年全球次世代定序服务市场占有率（按地区）
  • 北美洲
    • 北美次世代定序服务市场，2018-2030
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲次世代定序服务市场，2018-2030
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
    • 瑞士
  • 亚太地区
    • 亚太地区次世代定序服务市场，2018-2030
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
    • 新加坡
  • 拉丁美洲
    • 拉丁美洲次世代定序服务市场，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • MEA次世代定序服务市场，2018-2030
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章竞争形势

  • 公司分类
  • 策略规划
  • 2023 年企业市场/定位占有率分析
  • 公司简介/名单
    • Quest Diagnostics Incorporated
    • ARUP Laboratories
    • Applied Biological Materials, Inc.（abm）
    • Novogene Co, Ltd.
    • Azenta Life Sciences（GENEWIZ）
    • NanoString
    • Illumina, Inc.
    • PacBio
    • Veritas
    • BGI（Beijing Genomics Institute）
    • Gene by Gene Ltd.
    • Lucigen Corporation
Product Code: GVR-2-68038-630-1

Next-generation Sequencing Services Market Growth & Trends:

The global next-generation sequencing services market size is expected to reach USD 24.48 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 22.68% from 2024 to 2030. The development of next-generation sequencing (NGS) technologies has revolutionized gene sequencing in terms of reproducibility and cost savings. This has resulted in the introduction of several advancements in NGS technology to promote its usage in clinical labs and hospitals. Most current innovations in this field revolve around simplifying the usage of seq-technology and making it more sophisticated. These factors have driven the uptake of NGS services across various end-users.

Next-generation sequencing has progressed from research to clinical use in the last five years. Around 14 nations have launched large-scale genome sequencing programs, with nearly 60 million people expected to have their genome analyzed by 2025. Conventional disease testing service providers have broadened their portfolio with a rising trend of seq-based genetic tests. For instance, ARUP Laboratories announced the release of new coronavirus tests in March 2022, and IDbyDNA, Inc. partnered with another firm to introduce new coronavirus tests, an NGS test for respiratory illnesses, to aid physicians in evaluating patients with pneumonia and some other respiratory problems.

With the rising trend of high throughput sequencing within the pharma and biotech industry, there is a need for more developments to improve the speed and convenience of high throughput seq-platforms and simplify workflows. As a result, companies are focusing on the development of solutions to simplify the amplification and purification of samples and starting input. In March 2022, Illumina, Inc. announced the release of TruSigh Oncology (TSO) Comprehensive (EU), a comprehensive diagnostic that evaluates several tumor genes and indicators to identify a patient's cancer's individual molecular profile. The in vitro diagnostic (IVD) kit would assist in influencing genomic decisions for patients with cancer across Europe, with its global debut taking place first in Europe.

Next-generation Sequencing Services Market Report Highlights:

  • By service type, human genome sequencing held the largest revenue share in 2023 owing to greater penetration of whole genome and whole exome sequencing
  • Gene regulation services, particularly small RNA sequencing and ChIP-seq, are anticipated to grow at a lucrative pace during the forecast period. Rising investment in RNA sequencing is fueling the growth of gene regulation services
  • The larger revenue share of sequencing services as compared to other workflow steps can be attributed to an increase in the installation of sequencing platforms. High maintenance and recovery costs of this step have also resulted in greater revenue generation
  • By end-use, the universities and other research entities segment held the largest revenue share in 2023 owing to the growing application of NGS technology for cancer prognosis as well as diagnosis and major projects taken up by academicians and universities
  • North America dominated the market in 2023 owing to higher penetration of the technology in this region and the availability of funds to employ the technique and derive research findings for disease targeting
  • Companies such as GENEWIZ and Novogene Corporation are engaged in offering NGS services based on platforms from major NGS developers. Companies such as Illumina and BGI, on the other hand, are involved in developing sequencing instruments and offering services to research entities
  • In November 2021, Novogene stated during the 44th Annual Gathering of Molecular Biological Society of Japan (MSBJ) in Japan that they will be launching single-cell sequencing services specifically for their Japanese customers
  • GENEWIZ scientists are assisting in identifying the NGS solution for the projects. The NeXT Dx Test was launched by Personalis, Inc. to assist oncologists in identifying new therapy and clinical trial choices for cancer patients

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Information analysis
    • 1.2.2. Market formulation & data visualization
    • 1.2.3. Data validation & publishing
  • 1.3. Information Procurement
    • 1.3.1. Primary Others
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Market Model
  • 1.7. Objectives
    • 1.7.1. Objective 1
    • 1.7.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Decline in sequencing prices
    • 3.3.2. Growing awareness pertaining to women & reproductive health
    • 3.3.3. Strategies undertaken for implementation of clinical NGS
  • 3.4. Market Restraint Analysis
    • 3.4.1. Challenges pertaining to implementation of large-scale NGS analysis workflows
    • 3.4.2. Analytical challenges in single cell sequencing
  • 3.5. Business Environment Analysis
    • 3.5.1. PESTEL Analysis
    • 3.5.2. Porter's Five Forces Analysis
    • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Service Type Business Analysis

  • 4.1. Global Next Generation Sequencing Services Market: Service Type Movement Analysis
  • 4.2. Human Genome Sequencing Services
    • 4.2.1. Human Genome Sequencing Services Market, 2018 - 2030 (USD Million)
  • 4.3. Single-Cell Sequencing Services
    • 4.3.1. Single-Cell Sequencing Services Market, 2018 - 2030 (USD Million)
  • 4.4. Microbial Genome-based Sequencing Services
    • 4.4.1. Microbial Genome-based Sequencing Services Market, 2018 - 2030 (USD Million)
  • 4.5. Gene Regulation Services
    • 4.5.1. Gene Regulation Services Market, 2018 - 2030 (USD Million)
    • 4.5.2. Small RNA Sequencing Services
      • 4.5.2.1. Small RNA Sequencing Services Market, 2018 - 2030 (USD Million)
    • 4.5.3. Chip Sequencing Services
      • 4.5.3.1. Chip Sequencing Services Market, 2018 - 2030 (USD Million)
    • 4.5.4. Other Gene Regulation-based Service
      • 4.5.4.1. Other Gene Regulation-based Service Market, 2018 - 2030 (USD Million)
  • 4.6. Animal & Plant Sequencing Services
    • 4.6.1. Animal & Plant Sequencing Services Market, 2018 - 2030 (USD Million)
  • 4.7. Other Sequencing Services
    • 4.7.1. Other Sequencing Services Market, 2018 - 2030 (USD Million)

Chapter 5. Workflow Business Analysis

  • 5.1. Global Next Generation Sequencing Services market: Workflow Movement Analysis
  • 5.2. Pre Sequencing Service
    • 5.2.1. Pre Sequencing Service Market, 2018 - 2030 (USD Million)
  • 5.3. Sequencing Service
    • 5.3.1. Sequencing Service Market, 2018 - 2030 (USD Million)
  • 5.4. Data Analysis Service
    • 5.4.1. Data Analysis Service Market, 2018 - 2030 (USD Million)

Chapter 6. End-use Business Analysis

  • 6.1. Global Next Generation Sequencing Services Market: End-use Movement Analysis
  • 6.2. Universities & Other Research Entities
    • 6.2.1. Universities & Other Research Entities Market, 2018 - 2030 (USD Million)
  • 6.3. Hospitals & Clinics
    • 6.3.1. Hospitals & Clinics Market, 2018 - 2030 (USD Million)
  • 6.4. Pharma & Biotech Entities
    • 6.4.1. Pharma & Biotech Entities Market, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Global Next generation sequencing services market Share By Region, 2022 & 2030
  • 7.2. North America
    • 7.2.1. North America Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Competitive Scenario
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. Target Disease Prevalence
      • 7.2.2.5. U.S. Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Target Disease Prevalence
      • 7.2.3.5. Canada Next generation sequencing services market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.3.2. Germany
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. Target Disease Prevalence
      • 7.3.2.5. Germany Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.3.3. UK
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Target Disease Prevalence
      • 7.3.3.5. UK Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Target Disease Prevalence
      • 7.3.4.5. France Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Target Disease Prevalence
      • 7.3.5.5. Italy Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Target Disease Prevalence
      • 7.3.6.5. Spain Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Target Disease Prevalence
      • 7.3.7.5. Denmark Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Target Disease Prevalence
      • 7.3.8.5. Sweden Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Target Disease Prevalence
      • 7.3.9.5. Norway Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.3.10. Switzerland
      • 7.3.10.1. Key Country Dynamics
      • 7.3.10.2. Competitive Scenario
      • 7.3.10.3. Regulatory Framework
      • 7.3.10.4. Target Disease Prevalence
      • 7.3.10.5. Switzerland Next generation sequencing services market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Target Disease Prevalence
      • 7.4.2.5. Japan Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Target Disease Prevalence
      • 7.4.3.5. China Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Target Disease Prevalence
      • 7.4.4.5. India Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Target Disease Prevalence
      • 7.4.5.5. South Korea Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Target Disease Prevalence
      • 7.4.6.5. Australia Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Target Disease Prevalence
      • 7.4.7.5. Thailand Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.4.8. Singapore
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Framework
      • 7.4.8.4. Target Disease Prevalence
      • 7.4.8.5. Singapore Next generation sequencing services market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Target Disease Prevalence
      • 7.5.2.5. Brazil Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Target Disease Prevalence
      • 7.5.3.5. Mexico Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Target Disease Prevalence
      • 7.5.4.5. Argentina Next generation sequencing services market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Target Disease Prevalence
      • 7.6.2.5. South Africa Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Target Disease Prevalence
      • 7.6.3.5. Saudi Arabia Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Target Disease Prevalence
      • 7.6.4.5. UAE Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Target Disease Prevalence
      • 7.6.5.5. Kuwait Next generation sequencing services market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market/Position Share Analysis, 2023
  • 8.4. Company Profiles/Listing
    • 8.4.1. Quest Diagnostics Incorporated
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. ARUP Laboratories
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Applied Biological Materials, Inc. (abm)
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Novogene Co, Ltd.
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Azenta Life Sciences (GENEWIZ)
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. NanoString
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Illumina, Inc.
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. PacBio
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Veritas
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. BGI (Beijing Genomics Institute)
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives
    • 8.4.11. Gene by Gene Ltd.
      • 8.4.11.1. Overview
      • 8.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.11.3. Product Benchmarking
      • 8.4.11.4. Strategic Initiatives
    • 8.4.12. Lucigen Corporation
      • 8.4.12.1. Overview
      • 8.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.12.3. Product Benchmarking
      • 8.4.12.4. Strategic Initiatives

List of Tables

  • Table 1 List Of Secondary Sources
  • Table 2 List Of Abbreviations
  • Table 3 Global next generation sequencing services market by service type, 2018 - 2030 (USD Million)
  • Table 4 Global next generation sequencing services market by workflow, 2018 - 2030 (USD Million)
  • Table 5 Global next generation sequencing services market by end-use, 2018 - 2030 (USD Million)
  • Table 6 North America next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 7 North America next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 8 North America next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 9 North America next-generation sequencing services market estimates & forecasts, by country, 2018 - 2030 (USD Million)
  • Table 10 U.S. next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 11 U.S. next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 12 U.S. next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 13 Canada next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 14 Canada next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 15 Canada next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Europe next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 17 Europe next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 18 Europe next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Europe next-generation sequencing services market estimates & forecasts, by country, 2018 - 2030 (USD Million)
  • Table 20 Germany next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 21 Germany next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 22 Germany next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 23 UK next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 24 UK next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 25 UK next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 26 France next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 27 France next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 28 France next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Italy next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 30 Italy next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 31 Italy next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 32 Spain next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 33 Spain next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 34 Spain next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 35 Denmark next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 36 Denmark next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 37 Denmark next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 38 Sweden next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 39 Sweden next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 40 Sweden next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Norway next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 42 Norway next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 43 Norway next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 44 Switzerland next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 45 Switzerland next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 46 Switzerland next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific next-generation sequencing services market estimates & forecasts, by country, 2018 - 2030 (USD Million)
  • Table 51 Japan next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 52 Japan next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 53 Japan next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 54 China next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 55 China next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 56 China next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 57 India next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 58 India next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 59 India next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 60 Australia next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 61 Australia next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 62 Australia next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 63 South Korea next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 64 South Korea next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 65 South Korea next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 66 Thailand next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 67 Thailand next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 68 Thailand next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Singapore next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 70 Singapore next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 71 Singapore next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 72 Latin America next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 73 Latin America next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 74 Latin America next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Latin America next-generation sequencing services market estimates & forecasts, by country, 2018 - 2030 (USD Million)
  • Table 76 Brazil next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 77 Brazil next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 78 Brazil next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 79 Mexico next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 80 Mexico next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 81 Mexico next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 82 Argentina next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 83 Argentina next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 84 Argentina next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 85 MEA next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 86 MEA next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 87 MEA next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 88 MEA next-generation sequencing services market estimates & forecasts, by country, 2018 - 2030 (USD Million)
  • Table 89 South Africa next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 90 South Africa next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 91 South Africa next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 92 Saudi Arabia next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 93 Saudi Arabia next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 94 Saudi Arabia next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 95 UAE next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 96 UAE next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 97 UAE next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 98 Kuwait next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 99 Kuwait next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 100 Kuwait next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 101 Participant's Overview
  • Table 102 Financial Performance
  • Table 103 Key Companies Undergoing Expansions
  • Table 104 Key Companies Undergoing Acquisitions
  • Table 105 Key Companies Undergoing Collaborations
  • Table 106 Key Companies Launching New Products/Services
  • Table 107 Key Companies Undergoing Partnerships
  • Table 108 Key Companies Undertaking Other Strategies

List of Figures

  • Fig. 1 Market Others process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary Others pattern
  • Fig. 4 Market Others approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market summary, 2023 (USD Million)
  • Fig. 9 Market segmentation & scope
  • Fig. 10 Market driver impact
  • Fig. 11 Market restraint impact
  • Fig. 12 Penetration & growth prospect mapping
  • Fig. 13 Porter's analysis
  • Fig. 14 SWOT analysis
  • Fig. 15 Next-generation sequencing services market: Service type outlook and key takeaways
  • Fig. 16 Next-generation sequencing services market: Service type movement analysis
  • Fig. 17 Human genome sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Single-cell sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Microbial genome-based sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Gene regulation services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Small RNA sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Chip sequencing service market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Other gene regulation-based service market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Animal & plant sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Other sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Next-generation sequencing services market: Workflow outlook and key takeaways
  • Fig. 27 Next generation sequencing services market: Workflow movement analysis
  • Fig. 28 Pre sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Data analysis service market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Next-generation sequencing services market: End-use outlook and key takeaways
  • Fig. 32 Next-generation sequencing services market: End-use movement analysis
  • Fig. 33 Universities & other research entities, 2018 - 2030 (USD Million)
  • Fig. 34 Hospitals & clinics, 2018 - 2030 (USD Million)
  • Fig. 35 Pharma & biotech entities, 2018 - 2030 (USD Million)
  • Fig. 36 Other end-use, 2018 - 2030 (USD Million)
  • Fig. 37 Global next generation sequencing services market: Regional outlook and key takeaways
  • Fig. 38 North America next generation sequencing services market, 2018 - 2030 (USD million)
  • Fig. 39 US key country dynamics
  • Fig. 40 US next generation sequencing services market, 2018 - 2030 (USD million)
  • Fig. 41 Canada key country dynamics
  • Fig. 42 Canada next generation sequencing services market, 2018 - 2030 (USD million)
  • Fig. 43 Europe next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 44 Germany key country dynamics
  • Fig. 45 Germany next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 46 France key country dynamics
  • Fig. 47 France next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 48 UK key country dynamics
  • Fig. 49 UK next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 50 Italy key country dynamics
  • Fig. 51 Italy next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 52 Spain key country dynamics
  • Fig. 53 Spain next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 54 Denmark key country dynamics
  • Fig. 55 Denmark next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 56 Sweden key country dynamics
  • Fig. 57 Sweden next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 58 Norway key country dynamics
  • Fig. 59 Norway next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 60 Switzerland key country dynamics
  • Fig. 61 Switzerland next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 62 Asia-Pacific next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 63 China key country dynamics
  • Fig. 64 China next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 65 India key country dynamics
  • Fig. 66 India next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 67 South Korea key country dynamics
  • Fig. 68 South Korea next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 69 Japan key country dynamics
  • Fig. 70 Japan next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 71 Australia key country dynamics
  • Fig. 72 Australia next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 73 Thailand key country dynamics
  • Fig. 74 Thailand next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 75 Singapore key country dynamics
  • Fig. 76 Singopore next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 77 Latin America next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 78 Brazil key country dynamics
  • Fig. 79 Brazil next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 80 Mexico key country dynamics
  • Fig. 81 Mexico next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 82 Argentina key country dynamics
  • Fig. 83 Argentina next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 84 MEA next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 85 South Africa key country dynamics
  • Fig. 86 South Africa next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 87 Saudi Arabia key country dynamics
  • Fig. 88 Saudi Arabia next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 89 UAE key country dynamics
  • Fig. 90 UAE next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 91 Kuwait key country dynamics
  • Fig. 92 Kuwait next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 93 Market participant categorization
  • Fig. 94 Next generation sequencing services market share analysis, 2023
  • Fig. 95 Strategy framework